Rossi Esther, Bizzarro Tommaso, Martini Maurizio, Longatto-Filho Adhemar, Schmitt Fernando, Fagotti Anna, Scambia Giovanni, Zannoni Gian Franco
Division of Anatomic Pathology and Histology - Università Cattolica del Sacro Cuore, "Agostino Gemelli" School of Medicine, Rome, Italy.
Department of Pathology, University of São Paulo School of Medicine, Sao Paolo, Brazil.
PLoS One. 2017 Jan 18;12(1):e0168625. doi: 10.1371/journal.pone.0168625. eCollection 2017.
The cytological analysis of peritoneal effusions serves as a diagnostic and prognostic aid for either primary or metastatic diseases. Among the different cytological preparations, liquid based cytology (LBC) represents a feasible and reliable method ensuring also the application of ancillary techniques (i.e immunocytochemistry-ICC and molecular testing).
We recorded 10348 LBC peritoneal effusions between January 2000 and December 2014. They were classified as non-diagnostic (ND), negative for malignancy-NM, atypical-suspicious for malignancy-SM and positive for malignancy-PM.
The cytological diagnosis included 218 ND, 9.035 NM, 213 SM and 882 PM. A total of 8048 (7228 NM, 115SM, 705 PM) cases with histological follow-up were included. Our NM included 21 malignant and 7207 benign histological diagnoses. Our 820 SMs+PMs were diagnosed as 107 unknown malignancies (30SM and 77PM), 691 metastatic lesions (81SM and 610PM), 9 lymphomas (2SM and 7PM), 9 mesotheliomas (1SM and 8SM), 4 sarcomas (1SM and 3PM). Primary gynecological cancers contributed with 64% of the cases. We documented 97.4% sensitivity, 99.9% specificity, 98% diagnostic accuracy, 99.7% negative predictive value (NPV) and 99.7% positive predictive value (PPV). Furthermore, the morphological diagnoses were supported by either 173 conclusive ICC results or 50 molecular analyses. Specifically the molecular testing was performed for the EGFR and KRAS mutational analysis based on the previous or contemporary diagnoses of Non Small Cell Lung Cancer (NSCLC) and colon carcinomas. We identified 10 EGFR in NSCCL and 7 KRAS mutations on LBC stored material.
Peritoneal cytology is an adjunctive tool in the surgical management of tumors mostly gynecological cancers. LBC maximizes the application of ancillary techniques such as ICC and molecular analysis with feasible diagnostic and predictive yields also in controversial cases.
腹腔积液的细胞学分析可辅助诊断原发性或转移性疾病,并判断预后。在不同的细胞学检查方法中,液基细胞学(LBC)是一种可行且可靠的方法,还能应用辅助技术(如免疫细胞化学-ICC和分子检测)。
我们记录了2000年1月至2014年12月期间的10348例LBC腹腔积液病例。这些病例被分类为非诊断性(ND)、恶性阴性(NM)、非典型-可疑恶性(SM)和恶性阳性(PM)。
细胞学诊断包括218例ND、9035例NM、213例SM和882例PM。共有8048例(7228例NM、115例SM、705例PM)有组织学随访结果。我们的NM病例包括21例恶性组织学诊断和7207例良性组织学诊断。我们的820例SM+PM病例被诊断为107例未知恶性肿瘤(30例SM和77例PM)、691例转移瘤(81例SM和610例PM)、9例淋巴瘤(2例SM和7例PM)、9例间皮瘤(1例SM和8例PM)、4例肉瘤(1例SM和3例PM)。原发性妇科癌症占病例数的64%。我们记录的敏感性为97.4%,特异性为99.9%,诊断准确性为98%,阴性预测值(NPV)为99.7%,阳性预测值(PPV)为99.7%。此外,形态学诊断得到了173例确定性ICC结果或50例分子分析的支持。具体而言,基于既往或同期非小细胞肺癌(NSCLC)和结肠癌的诊断,对EGFR和KRAS进行了突变分析。我们在LBC保存材料中鉴定出10例NSCCL中的EGFR突变和7例KRAS突变。
腹腔细胞学是肿瘤(主要是妇科癌症)手术治疗中的辅助工具。LBC最大限度地应用了ICC和分子分析等辅助技术,在有争议的病例中也能获得可行的诊断和预测结果。